| Ms Kelley Anne Nelligan, RN, MSN, CPNP | |
|
1011 Veterans Memorial Pkwy, Riverside, RI 02915-5061 | |
| (401) 432-1325 | |
| Not Available |
| Full Name | Ms Kelley Anne Nelligan |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Pediatrics |
| Location | 1011 Veterans Memorial Pkwy, Riverside, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053430702 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0200X | Nurse Practitioner - Pediatrics | 262959 (Massachusetts) | Secondary |
| 363LP0200X | Nurse Practitioner - Pediatrics | APRN01484 (Rhode Island) | Primary |
| Entity Name | Emma Pendleton Bradley Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578768867 PECOS PAC ID: 3870527526 Enrollment ID: O20050921001082 |
News Archive
The Pan American Health Organization (PAHO) has issued an urgent appeal for $543,000 to support immediate health needs in Guyana, where heavy rainfall has flooded densely populated areas, leaving thousands without shelter, food or water.
A University of Toronto (Toronto, Canada) research team, led by G. Harvey Anderson, Ph.D., just published results of a new study in the American Journal of Clinical Nutrition, showing that the quantity of resistant starch in foods correlates with blood glucose response and reduced food intake after two hours.
Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India, announced today that it is setting up Niacinamide and 3-Cyanopyridine plant of 10,000 TPA each, expected to be ready by end of 2010.
Millennium: The Takeda Oncology Company today reported the presentation of results of a randomized Phase III trial that investigated the effect of consolidation with single-agent VELCADE for Injection in newly diagnosed multiple myeloma patients after autologous stem cell transplant.
Liver toxicity is one of the main reasons pharmaceutical companies pull drugs off the market. These dangerous drugs slip through approval processes due in part to the shortcomings of liver toxicity tests. Existing tests rely on liver cells from rats, which do not always respond to toxins the way human cells do. Or they rely on dying human cells that survive for only a few days in the lab.
› Verified 4 days ago
| Entity Name | Lifespan Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548506793 PECOS PAC ID: 2567455082 Enrollment ID: O20130528000089 |
News Archive
The Pan American Health Organization (PAHO) has issued an urgent appeal for $543,000 to support immediate health needs in Guyana, where heavy rainfall has flooded densely populated areas, leaving thousands without shelter, food or water.
A University of Toronto (Toronto, Canada) research team, led by G. Harvey Anderson, Ph.D., just published results of a new study in the American Journal of Clinical Nutrition, showing that the quantity of resistant starch in foods correlates with blood glucose response and reduced food intake after two hours.
Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India, announced today that it is setting up Niacinamide and 3-Cyanopyridine plant of 10,000 TPA each, expected to be ready by end of 2010.
Millennium: The Takeda Oncology Company today reported the presentation of results of a randomized Phase III trial that investigated the effect of consolidation with single-agent VELCADE for Injection in newly diagnosed multiple myeloma patients after autologous stem cell transplant.
Liver toxicity is one of the main reasons pharmaceutical companies pull drugs off the market. These dangerous drugs slip through approval processes due in part to the shortcomings of liver toxicity tests. Existing tests rely on liver cells from rats, which do not always respond to toxins the way human cells do. Or they rely on dying human cells that survive for only a few days in the lab.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Kelley Anne Nelligan, RN, MSN, CPNP 117 Ellenfield St Ste 101, Providence, RI 02905-4513 Ph: (401) 444-6779 | Ms Kelley Anne Nelligan, RN, MSN, CPNP 1011 Veterans Memorial Pkwy, Riverside, RI 02915-5061 Ph: (401) 432-1325 |
News Archive
The Pan American Health Organization (PAHO) has issued an urgent appeal for $543,000 to support immediate health needs in Guyana, where heavy rainfall has flooded densely populated areas, leaving thousands without shelter, food or water.
A University of Toronto (Toronto, Canada) research team, led by G. Harvey Anderson, Ph.D., just published results of a new study in the American Journal of Clinical Nutrition, showing that the quantity of resistant starch in foods correlates with blood glucose response and reduced food intake after two hours.
Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India, announced today that it is setting up Niacinamide and 3-Cyanopyridine plant of 10,000 TPA each, expected to be ready by end of 2010.
Millennium: The Takeda Oncology Company today reported the presentation of results of a randomized Phase III trial that investigated the effect of consolidation with single-agent VELCADE for Injection in newly diagnosed multiple myeloma patients after autologous stem cell transplant.
Liver toxicity is one of the main reasons pharmaceutical companies pull drugs off the market. These dangerous drugs slip through approval processes due in part to the shortcomings of liver toxicity tests. Existing tests rely on liver cells from rats, which do not always respond to toxins the way human cells do. Or they rely on dying human cells that survive for only a few days in the lab.
› Verified 4 days ago
Penny Marie Mclean-nowinski, MSN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1445 Wampanoag Trl Unit 205, Riverside, RI 02915 Phone: 401-434-0730 Fax: 401-270-3439 | |
Mrs. Shannon Fultz, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3 Myrtle Ave, Riverside, RI 02915 Phone: 603-765-1431 | |
Donna Marie Rondeau-marzullo, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Suite 102, Riverside, RI 02915 Phone: 401-649-4010 Fax: 401-649-4011 | |
Miss Paula Holmes Constantine, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 375 Wampanoag Trl Ste 102, Riverside, RI 02915 Phone: 401-649-4010 Fax: 401-649-4011 | |
Ms. Britni Turano, MS RN PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1445 Wampanoag Trl Unit 202, Riverside, RI 02915 Phone: 401-437-4116 | |
Mr. David John Ramos, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 501 Wampanoag Trl Unit 102, Riverside, RI 02915 Phone: 401-435-3325 Fax: 401-435-3327 |